☆ 4.6 Article

DHX38 enhances proliferation, metastasis, and EMT progression in NSCLC through the G3BP1-mediated MAPK pathway

CELLULAR SIGNALLING (2024)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAFV600 mutation- positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study

Paolo A. Ascierto et al.

Summary: The phase 3 IMspire150 study showed improved investigator-assessed progression-free survival with atezolizumab, vemurafenib, and cobimetinib in patients with BRAFV600 mutation-positive melanoma. However, the interim overall survival analysis did not demonstrate a significant improvement in overall survival compared to the control group.

LANCET ONCOLOGY (2023)

添加到收藏夹

Article Genetics & Heredity

DHX38 restricts chemoresistance by regulating the alternative pre-mRNA splicing of RELL2 in pancreatic ductal adenocarcinoma

Zeru Li et al.

Summary: The study identified a new intron retention gene in pancreatic ductal adenocarcinoma, which is regulated by the upstream splicer DHX38. The reduction of DHX38 expression leads to the retention of the fourth intron of RELL2, causing nonsense-mediated mRNA decay and inhibiting apoptosis of pancreatic cancer cells, ultimately promoting drug resistance. This research provides a potential therapeutic target for pancreatic ductal adenocarcinoma.

PLOS GENETICS (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

The splicing factor DHX38/PRP16 is required for ovarian clear cell carcinoma tumorigenesis, as revealed by a CRISPR-Cas9 screen

Brandon Cona et al.

Summary: The gene DHX38/PRP16 has been identified as critical for the growth and tumorigenesis of ovarian clear cell carcinoma (OCCC), and could potentially be a promising therapeutic target.

FEBS OPEN BIO (2022)

添加到收藏夹

Article Oncology

RAF-MEK-ERK pathway in cancer evolution and treatment

Rahim Ullah et al.

Summary: The RAF-MEK-ERK signaling cascade is a well-characterized MAPK pathway that plays a critical role in cell proliferation and survival. Genetic alterations in this pathway are highly prevalent in human cancers and can lead to uncontrolled cell growth and tumor formation. The crosstalk between the RAF-MEK-ERK axis and other signaling pathways further enhances its proliferative potential in human cancers.

SEMINARS IN CANCER BIOLOGY (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Retinitis pigmentosa-linked mutation in DHX38 modulates its splicing activity

Mina Obuca et al.

Summary: This study analyzed the role of RNA helicase DHX38 in retinitis pigmentosa (RP). The findings showed that DHX38 is associated with key splicing factors, regulates alternative splicing and promotes the usage of cryptic splice sites. The RP-linked substitution G332D modulates DHX38's splicing activity.

PLOS ONE (2022)

添加到收藏夹

Editorial Material Cell Biology

EGFR Signaling in Non-Small Cell Lung Cancer: From Molecular Mechanisms to Therapeutic Opportunities

Silvia La Monica

CELLS (2022)

添加到收藏夹

Article Oncology

Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL) : a multicentre, open-label, single-arm, phase 2 study

Reinhard Dummer et al.

Summary: This study evaluated the use of atezolizumab in combination with cobimetinib or vemurafenib plus cobimetinib for patients with melanoma with CNS metastases. The results showed that the combination of atezolizumab and vemurafenib plus cobimetinib provided promising intracranial activity in patients with BRAF(V60)-mutated melanoma with CNS metastases.

LANCET ONCOLOGY (2022)

添加到收藏夹

Article Oncology

FOXD1-dependent RalA-ANXA2-Src complex promotes CTC formation in breast cancer

Yufei Long et al.

Summary: In this study, a FOXD1-dependent RalA-ANXA2-Src complex that promotes CTC formation via activating ERK1/2 signal in BC was discovered. FOXD1 may serve as a prognostic factor in evaluating BC metastasis risks. This signaling cascade is druggable and effective for overcoming early stages of BC CTC formation.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

A renewed concept on the MAPK signaling pathway in cancers: Polyphenols as a choice of therapeutics

Juhaer Anjum et al.

Summary: Abnormalities in the MAPK signaling pathway contribute to carcinogenesis, while polyphenols can modulate this pathway to inhibit cancer cell growth and metastasis.

PHARMACOLOGICAL RESEARCH (2022)

添加到收藏夹

Review Oncology

Molecular testing and targeted therapy for non-small cell lung cancer: Current status and perspectives

Evgeny N. Imyanitov et al.

Summary: Molecular testing is essential in NSCLC management, including detecting mutations and translocations, as well as analyzing protein expression. Efforts are ongoing to integrate multiple molecular assays into a single diagnostic pipeline for NSCLC.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

Anticancer drug resistance: An update and perspective

Ruth Nussinov et al.

Summary: Driver mutations play a critical role in cancer initiation and progression, with drug resistance being a common challenge in pharmacological treatment. The emergence of drug resistance can be attributed to a variety of mechanisms, such as mutations occurring in the same or different proteins, and in the same or parallel pathways. The complexity of genetic alterations and tumor microenvironment changes poses challenges in predicting drug resistance and requires further research in precision medicine.

DRUG RESISTANCE UPDATES (2021)

添加到收藏夹

Review Oncology

MEK inhibitors for the treatment of non-small cell lung cancer

Jing Han et al.

Summary: BRAF and KRAS mutations play a significant role in NSCLC by activating the RAS/RAF/MEK/ERK signaling pathway. Current approved therapies include BRAF and MEK inhibitors, while combination with other drugs may enhance therapeutic effects. Further research is needed to explore optimal drug combinations for treating lung cancer patients.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

添加到收藏夹

Article Oncology

HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer

Yiwei Huang et al.

Summary: The study reveals that TGF-beta plays a dual role in regulating glycolysis and cell proliferation in non-small cell lung cancer. HIF-1 alpha is identified as a critical factor in this process, potentially serving as a biomarker or therapeutic target for TGF-beta mediated cancer progression. The research findings provide insight into the metabolic reprogramming mechanisms in tumor cells.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

添加到收藏夹

Article Oncology

STOML2 interacts with PHB through activating MAPK signaling pathway to promote colorectal Cancer proliferation

Wenhui Ma et al.

Summary: In colorectal cancer, STOML2 is overexpressed and interacts with PHB to activate the MAPK signaling pathway, promoting proliferation both in vitro and in vivo. The combination of screening assays and bioinformatics is of great significance in exploring the regulatory mechanism of proteins of interest.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

添加到收藏夹

Article Multidisciplinary Sciences

G3BP1 inhibits Cul3SPOP to amplify AR signaling and promote prostate cancer

Chandrani Mukhopadhyay et al.

Summary: This study reveals that G3BP1 acts as a competitive inhibitor of SPOP, promoting tumorigenesis in prostate cancer by activating androgen signaling. Furthermore, AR directly upregulates G3BP1 transcription to amplify G3BP1-SPOP signaling in a feed-forward manner.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Oncology

Mex3a promotes oncogenesis through the RAP1/MAPK signaling pathway in colorectal cancer and is inhibited by hsa-miR-6887-3p

Haixia Li et al.

Summary: The study demonstrated that Mex3a plays a significant role in colorectal cancer (CRC) by regulating the RAP1GAP/MEK/ERK/HIF-1α pathway. Mex3a was identified as a prognostic factor for overall survival in CRC patients, and knockdown of Mex3a inhibited tumor cell migration, invasion, and proliferation. Furthermore, hsa-miR-6887-3p was found to downregulate Mex3a expression and inhibit CRC tumorigenesis both in vitro and in vivo.

CANCER COMMUNICATIONS (2021)

添加到收藏夹

Letter Oncology

Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapy

J. Remon et al.

ANNALS OF ONCOLOGY (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Interplay between MAPK/ERK signaling pathway and MicroRNAs: A crucial mechanism regulating cancer cell metabolism and tumor progression

Elmira Roshani Asl et al.

Summary: The highly conserved MAPK signal transduction pathway plays a crucial role in cancer progression, while miRNAs act as critical regulators in cancer initiation and progression. The interaction between miRNAs and the MAPK signaling pathway is pivotal in the development of human cancers.

LIFE SCIENCES (2021)

添加到收藏夹

Review Immunology

Research Progress on the Structure and Function of G3BP

Weifang Kang et al.

Summary: G3BP is an RNA binding protein involved in stress granule formation and antiviral responses. It plays a role in regulating gene expression and is associated with the progression of various diseases.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Oncology

Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations

J. Mazieres et al.

ANNALS OF ONCOLOGY (2020)

添加到收藏夹

Review Medicine, Research & Experimental

Telmisartan inhibits oxalate and calcium oxalate crystal-induced epithelial-mesenchymal transformation via PPAR-γ-AKT/STAT3/p38 MAPK-Snail pathway

Yadong Liu et al.

LIFE SCIENCES (2020)

添加到收藏夹

Review Cell Biology

Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy

Ufuk Degirmenci et al.

CELLS (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

G3BP1 Is a Tunable Switch that Triggers Phase Separation to Assemble Stress Granules

Peiguo Yang et al.

CELL (2020)

添加到收藏夹

Article Medicine, General & Internal

Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial

Ralf Gutzmer et al.

LANCET (2020)

添加到收藏夹

Review Oncology

The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy

Jimin Yuan et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma

Reinhard Dummer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Editorial Material Multidisciplinary Sciences

Lung cancer

Herb Brody

NATURE (2020)

添加到收藏夹

Review Oncology

Targeting EMT in Cancer with Repurposed Metabolic Inhibitors

Vignesh Ramesh et al.

TRENDS IN CANCER (2020)

添加到收藏夹

Review Respiratory System

Update 2020: Management of Non-Small Cell Lung Cancer

Mariam Alexander et al.

LUNG (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

The roles and mechanisms of G3BP1 in tumour promotion

Cong-Hui Zhang et al.

JOURNAL OF DRUG TARGETING (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

Targeting the ERK Signaling Pathway in Melanoma

Paola Savoia et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer

Kirsten L. Bryant et al.

NATURE MEDICINE (2019)

添加到收藏夹

Review Medicine, General & Internal

KRAS-mutant non-small cell lung cancer: Converging small molecules and immune checkpoint inhibition

Helen Adderley et al.

EBIOMEDICINE (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance

Micol Eleonora Fiori et al.

MOLECULAR CANCER (2019)

添加到收藏夹

Review Pharmacology & Pharmacy

Targeting ERK1/2 protein-serine/threonine kinases in human cancers

Robert Roskoski

PHARMACOLOGICAL RESEARCH (2019)

添加到收藏夹

Article Oncology

Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial

Cathy Eng et al.

LANCET ONCOLOGY (2019)

添加到收藏夹

Article Medicine, General & Internal

Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma

C. Robert et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

添加到收藏夹

Review Medicine, General & Internal

Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer A Review

Kathryn C. Arbour et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

添加到收藏夹

Review Medicine, General & Internal

Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment

Narjust Duma et al.

MAYO CLINIC PROCEEDINGS (2019)

添加到收藏夹

Article Immunology

G3BP1 promotes DNA binding and activation of cGAS

Zhao-Shan Liu et al.

NATURE IMMUNOLOGY (2019)

添加到收藏夹

Review Cell Biology

EMT Transition States during Tumor Progression and Metastasis

Ievgenia Pastushenko et al.

TRENDS IN CELL BIOLOGY (2019)

添加到收藏夹

Article Oncology

A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53

Chao Mao et al.

CANCER RESEARCH (2018)

添加到收藏夹

Article Cell Biology

HCC-derived exosomes elicit HCC progression and recurrence by epithelialmesenchymal transition through MAPK/ ERK signalling pathway

Lu Chen et al.

CELL DEATH & DISEASE (2018)

添加到收藏夹

Article Ophthalmology

Confirmation of the Role of DHX38 in the Etiology of Early-Onset Retinitis Pigmentosa

Zahid Latif et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2018)

添加到收藏夹

Review Multidisciplinary Sciences

The biology and management of non-small cell lung cancer

Roy S. Herbst et al.

NATURE (2018)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.